Tectonic Therapeutic

TECXNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$584.567 M

$30.98 +2.52%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$74.2B

Loss-making

Shares outstanding

19,549,366

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#58Agomab TherapeuticsAGMB$714.1M
#59Allogene TherapeuticsALLO$693.8M
#60Tectonic TherapeuticTECX$584.6M
#61Zura BioZURA$566.7M
#624D Molecular TherapeuticsFDMT$562.0M

Where these numbers come from

Share counts and financials for Tectonic Therapeutic are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.